Company intelligence / Profile preview

DaRev

San Diego, CA, USAdarev.tech ↗
Ownership
Private
Development stage
Other
01

Overview

Daré Bioscience has one FDA-approved product—XACIATO™ (clindamycin phosphate vaginal gel) for bacterial vaginosis—and a broad pipeline targeting women’s health needs in contraception, sexual health, menopause, and fertility. Its lead programs include Ovaprene® (a hormone-free monthly contraceptive ring), Sildenafil Cream for female sexual arousal disorder, DARE-HRT1 intravaginal ring for menopausal hormone therapy, and the DARE-LARC1 long-term implantable drug/device platform. The company partners with major pharma companies like Bayer and Organon to commercialize its products.

Therapeutic areas
Women's Health
Modalities
Small moleculeDeviceHormoneCream formulationHydrogel-based drug delivery therapyIntravaginal ring (device/drug combination)
Industry
Biotech
02

Partnerships

Bayer (US rights to Ovaprene)Organon (global license agreement on XACIATO)Theramex (collaborator on Casea S biodegradable contraceptive)

Beyond the preview

Go deeper on DaRev.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DaRev.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call